Live Chat

I CFD sono strumenti complessi e presentano un alto rischio di perdere soldi rapidamente a causa della leva finanziaria. Il 76,3% dei conti di clienti al dettaglio perde denaro facendo trading con i CFD con questo fornitore. Devi verificare se comprendi pienamente come funzionano i CFD e se puoi permetterti di correre il rischio elevato di perdere i tuoi soldi.

Close

Fai trading su Moderna Inc MRNA

Grafico live di Moderna

Percezioni e opinioni

Weekly Search
Weekly
Daily
date Chiudi change variazione % Apertura Massimo Minimo

Markets.com news

French election results to drive European markets
markets.com Support Team 2024 Jul 04, 21:00

La prossima settimana: I risultati delle elezioni francesi saranno chiave per i mercati europei

Forex Indici
Macron calls snap election, riles markets
markets.com Support Team 2024 Jun 29, 21:00

La prossima settimana: La Francia scatenerà una crisi dell'euro?

CPI
Businessman pointing hologram online banking icon.
markets.com Support Team 2024 Jun 20, 16:00

La prossima settimana: Una carrellata di dati e uno sguardo all’inflazione

Forex Indici
RBA, SNB, Bank of England rate decisions due next week
markets.com Support Team 2024 Jun 13, 21:00

La prossima settimana: RBA e Bank of England - status quo o cambio all’orizzonte?

Forex Indici

Informazioni

Spread

0.28

Spread (%)

0.6716 %

Leva

1:5

Interesse overnight acquisto

-0.0597 %

Interesse overnight vendita

-0.0292 %

Valuta

USD

Orari di trading

Markets closed

Martedì

14:31 - 20:59

Lunedì

14:31-20:59

Mercoledì

14:31-20:59

Giovedi

14:31-20:59

Venerdì

14:31-20:59

Conto economico

Apertura

---

Chiusura precedente

---

Massimo/Minimo di 52 settimane

--- – ---

Capitalizzazione di mercato

15234944000

Azioni in circolazione

384817984

Data delle trimestrali (prossima)

0000-00-00

instr__dividend_date

instr__ex_dividend_date

instr__forward_annual_dividend_rate

0

instr__forward_annual_dividend_yield

0

EPS

-5.81

Azioni in circolazione

Moderna Inc Moderna Inc
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Scopri di più su questo strumento

Strumenti correlati
Trustpilot
Live Chat